 | • レポートコード：QAF27510 • 出版社/出版日：QYResearch / 2021年4月7日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の動物用ワクチン市場について種類別（弱毒生ワクチン、不活化ワクチン、その他）、用途別（家畜、豚、鶏、犬・猫、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・動物用ワクチン市場の概要 ・世界の主要地域別動物用ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の動物用ワクチン市場規模2016-2021：種類別（弱毒生ワクチン、不活化ワクチン、その他） ・世界の動物用ワクチン市場予測2012-2027：種類別（弱毒生ワクチン、不活化ワクチン、その他） ・世界の動物用ワクチン市場規模2016-2021：用途別（家畜、豚、鶏、犬・猫、その他） ・世界の動物用ワクチン市場予測2012-2027：用途別（家畜、豚、鶏、犬・猫、その他） ・動物用ワクチンのアメリカ市場規模と予測2016-2021 ・動物用ワクチンのヨーロッパ市場規模と予測2016-2021 ・動物用ワクチンの中国市場規模と予測2016-2021 ・動物用ワクチンの日本市場規模と予測2016-2021 ・動物用ワクチンの東南アジア市場規模と予測2016-2021 ・動物用ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac、Jinyu Bio-Technology、ChengDu Tecbond、CAVAC、Kyoto Biken Laboratories、FATRO、Vaksindo、Bio-Labs、Avimex Animal Health、MEVAC、Biovac、Atafen、Dyntec、BioTestLab、RVSRI、Medion） ・動物用ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・動物用ワクチンの市場動向・機会・課題 ・調査の結論 |
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
There are four kinds of Veterinary Vaccine, which are Live Attenuated Vaccines, Inactivated Vaccines and others. Live attenuated vaccines hold the largest share of the veterinary vaccines market, with a sales market share nearly 48.9% in 2019, the live attenuated vaccines segment is mainly driven by factors such as the increasing prevalence of diseases among porcine and poultry animals as well as the ease of administration and long-term immunity offered by these vaccines.
Veterinary Vaccine is use in Livestock, Swine, Chicken and Dog & Cat. The most proportion of Veterinary Vaccine is used in Dog & Cat, and the market share in 2019 is about 34.77% and the proportion of Swine in 2019 is about 14.59%.
North America is the largest consumption place, with a consumption market share nearly 32.58% in 2019. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 31.3%.
Market competition is intense; Merck, Zoetis, Boehringer Ingelheim, Ceva, etc. are the leader of the industry, and top 3 players hold about 69.24% revenue market share, with high-end customers. They have formed global market channel of the industry. There are a lot of manufacturers in China, but the production quality is uneven.
Market Analysis and Insights: Global Veterinary Vaccine Market
The global Veterinary Vaccine market was valued at US$ 8270.4 in 2020 and will reach US$ 11800 million by the end of 2027, growing at a CAGR of 6.1% during 2022-2027.
Global Veterinary Vaccine Scope and Market Size
The global Veterinary Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Others
Segment by Application
Livestock
Swine
Chicken
Dog & Cat
Others
The Veterinary Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Veterinary Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
BioTestLab
RVSRI
Medion
1 Veterinary Vaccine Market Overview
1.1 Veterinary Vaccine Product Scope
1.2 Veterinary Vaccine Segment by Type
1.2.1 Global Veterinary Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Vaccine Segment by Application
1.3.1 Global Veterinary Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Dog & Cat
1.3.6 Others
1.4 Veterinary Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Veterinary Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Veterinary Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Veterinary Vaccine Price Trends (2016-2027)
2 Veterinary Vaccine Estimates and Forecasts by Region
2.1 Global Veterinary Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Veterinary Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Veterinary Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Veterinary Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Veterinary Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Veterinary Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Veterinary Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Veterinary Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Veterinary Vaccine Estimates and Projections (2016-2027)
2.4.3 China Veterinary Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Veterinary Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Veterinary Vaccine Estimates and Projections (2016-2027)
2.4.6 India Veterinary Vaccine Estimates and Projections (2016-2027)
3 Global Veterinary Vaccine Competition Landscape by Players
3.1 Global Top Veterinary Vaccine Players by Sales (2016-2021)
3.2 Global Top Veterinary Vaccine Players by Revenue (2016-2021)
3.3 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2020)
3.4 Global Veterinary Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Veterinary Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Veterinary Vaccine Market Size by Type
4.1 Global Veterinary Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Veterinary Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Veterinary Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Veterinary Vaccine Price by Type (2016-2021)
4.2 Global Veterinary Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Veterinary Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Veterinary Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Veterinary Vaccine Price Forecast by Type (2022-2027)
5 Global Veterinary Vaccine Market Size by Application
5.1 Global Veterinary Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Veterinary Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Veterinary Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Veterinary Vaccine Price by Application (2016-2021)
5.2 Global Veterinary Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Veterinary Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Veterinary Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Veterinary Vaccine Price Forecast by Application (2022-2027)
6 North America Veterinary Vaccine Market Facts & Figures
6.1 North America Veterinary Vaccine Sales by Company
6.1.1 North America Veterinary Vaccine Sales by Company (2016-2021)
6.1.2 North America Veterinary Vaccine Revenue by Company (2016-2021)
6.2 North America Veterinary Vaccine Sales Breakdown by Type
6.2.1 North America Veterinary Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Veterinary Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Veterinary Vaccine Sales Breakdown by Application
6.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Veterinary Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Veterinary Vaccine Market Facts & Figures
7.1 Europe Veterinary Vaccine Sales by Company
7.1.1 Europe Veterinary Vaccine Sales by Company (2016-2021)
7.1.2 Europe Veterinary Vaccine Revenue by Company (2016-2021)
7.2 Europe Veterinary Vaccine Sales Breakdown by Type
7.2.1 Europe Veterinary Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Veterinary Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Veterinary Vaccine Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Veterinary Vaccine Market Facts & Figures
8.1 China Veterinary Vaccine Sales by Company
8.1.1 China Veterinary Vaccine Sales by Company (2016-2021)
8.1.2 China Veterinary Vaccine Revenue by Company (2016-2021)
8.2 China Veterinary Vaccine Sales Breakdown by Type
8.2.1 China Veterinary Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Veterinary Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Veterinary Vaccine Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)
9 Japan Veterinary Vaccine Market Facts & Figures
9.1 Japan Veterinary Vaccine Sales by Company
9.1.1 Japan Veterinary Vaccine Sales by Company (2016-2021)
9.1.2 Japan Veterinary Vaccine Revenue by Company (2016-2021)
9.2 Japan Veterinary Vaccine Sales Breakdown by Type
9.2.1 Japan Veterinary Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Veterinary Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Veterinary Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Veterinary Vaccine Market Facts & Figures
10.1 Southeast Asia Veterinary Vaccine Sales by Company
10.1.1 Southeast Asia Veterinary Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Veterinary Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Veterinary Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Veterinary Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Veterinary Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Veterinary Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Veterinary Vaccine Market Facts & Figures
11.1 India Veterinary Vaccine Sales by Company
11.1.1 India Veterinary Vaccine Sales by Company (2016-2021)
11.1.2 India Veterinary Vaccine Revenue by Company (2016-2021)
11.2 India Veterinary Vaccine Sales Breakdown by Type
11.2.1 India Veterinary Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Veterinary Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Veterinary Vaccine Sales Breakdown by Application
11.3.1 India Veterinary Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Veterinary Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Veterinary Vaccine Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Veterinary Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 Zoetis
12.2.1 Zoetis Corporation Information
12.2.2 Zoetis Business Overview
12.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Zoetis Veterinary Vaccine Products Offered
12.2.5 Zoetis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Business Overview
12.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Veterinary Vaccine Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Ceva
12.4.1 Ceva Corporation Information
12.4.2 Ceva Business Overview
12.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ceva Veterinary Vaccine Products Offered
12.4.5 Ceva Recent Development
12.5 CAHIC
12.5.1 CAHIC Corporation Information
12.5.2 CAHIC Business Overview
12.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CAHIC Veterinary Vaccine Products Offered
12.5.5 CAHIC Recent Development
12.6 HVRI
12.6.1 HVRI Corporation Information
12.6.2 HVRI Business Overview
12.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 HVRI Veterinary Vaccine Products Offered
12.6.5 HVRI Recent Development
12.7 Ringpu Biology
12.7.1 Ringpu Biology Corporation Information
12.7.2 Ringpu Biology Business Overview
12.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ringpu Biology Veterinary Vaccine Products Offered
12.7.5 Ringpu Biology Recent Development
12.8 Yebio
12.8.1 Yebio Corporation Information
12.8.2 Yebio Business Overview
12.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Yebio Veterinary Vaccine Products Offered
12.8.5 Yebio Recent Development
12.9 DHN
12.9.1 DHN Corporation Information
12.9.2 DHN Business Overview
12.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 DHN Veterinary Vaccine Products Offered
12.9.5 DHN Recent Development
12.10 WINSUN
12.10.1 WINSUN Corporation Information
12.10.2 WINSUN Business Overview
12.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 WINSUN Veterinary Vaccine Products Offered
12.10.5 WINSUN Recent Development
12.11 Elanco
12.11.1 Elanco Corporation Information
12.11.2 Elanco Business Overview
12.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Elanco Veterinary Vaccine Products Offered
12.11.5 Elanco Recent Development
12.12 Virbac
12.12.1 Virbac Corporation Information
12.12.2 Virbac Business Overview
12.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Virbac Veterinary Vaccine Products Offered
12.12.5 Virbac Recent Development
12.13 Jinyu Bio-Technology
12.13.1 Jinyu Bio-Technology Corporation Information
12.13.2 Jinyu Bio-Technology Business Overview
12.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jinyu Bio-Technology Veterinary Vaccine Products Offered
12.13.5 Jinyu Bio-Technology Recent Development
12.14 ChengDu Tecbond
12.14.1 ChengDu Tecbond Corporation Information
12.14.2 ChengDu Tecbond Business Overview
12.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ChengDu Tecbond Veterinary Vaccine Products Offered
12.14.5 ChengDu Tecbond Recent Development
12.15 CAVAC
12.15.1 CAVAC Corporation Information
12.15.2 CAVAC Business Overview
12.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 CAVAC Veterinary Vaccine Products Offered
12.15.5 CAVAC Recent Development
12.16 Kyoto Biken Laboratories
12.16.1 Kyoto Biken Laboratories Corporation Information
12.16.2 Kyoto Biken Laboratories Business Overview
12.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kyoto Biken Laboratories Veterinary Vaccine Products Offered
12.16.5 Kyoto Biken Laboratories Recent Development
12.17 FATRO
12.17.1 FATRO Corporation Information
12.17.2 FATRO Business Overview
12.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 FATRO Veterinary Vaccine Products Offered
12.17.5 FATRO Recent Development
12.18 Vaksindo
12.18.1 Vaksindo Corporation Information
12.18.2 Vaksindo Business Overview
12.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Vaksindo Veterinary Vaccine Products Offered
12.18.5 Vaksindo Recent Development
12.19 Bio-Labs
12.19.1 Bio-Labs Corporation Information
12.19.2 Bio-Labs Business Overview
12.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Bio-Labs Veterinary Vaccine Products Offered
12.19.5 Bio-Labs Recent Development
12.20 Avimex Animal Health
12.20.1 Avimex Animal Health Corporation Information
12.20.2 Avimex Animal Health Business Overview
12.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Avimex Animal Health Veterinary Vaccine Products Offered
12.20.5 Avimex Animal Health Recent Development
12.21 MEVAC
12.21.1 MEVAC Corporation Information
12.21.2 MEVAC Business Overview
12.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 MEVAC Veterinary Vaccine Products Offered
12.21.5 MEVAC Recent Development
12.22 Biovac
12.22.1 Biovac Corporation Information
12.22.2 Biovac Business Overview
12.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Biovac Veterinary Vaccine Products Offered
12.22.5 Biovac Recent Development
12.23 Atafen
12.23.1 Atafen Corporation Information
12.23.2 Atafen Business Overview
12.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Atafen Veterinary Vaccine Products Offered
12.23.5 Atafen Recent Development
12.24 Dyntec
12.24.1 Dyntec Corporation Information
12.24.2 Dyntec Business Overview
12.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Dyntec Veterinary Vaccine Products Offered
12.24.5 Dyntec Recent Development
12.25 BioTestLab
12.25.1 BioTestLab Corporation Information
12.25.2 BioTestLab Business Overview
12.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.25.4 BioTestLab Veterinary Vaccine Products Offered
12.25.5 BioTestLab Recent Development
12.26 RVSRI
12.26.1 RVSRI Corporation Information
12.26.2 RVSRI Business Overview
12.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.26.4 RVSRI Veterinary Vaccine Products Offered
12.26.5 RVSRI Recent Development
12.27 Medion
12.27.1 Medion Corporation Information
12.27.2 Medion Business Overview
12.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Medion Veterinary Vaccine Products Offered
12.27.5 Medion Recent Development
13 Veterinary Vaccine Manufacturing Cost Analysis
13.1 Veterinary Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Veterinary Vaccine
13.4 Veterinary Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Veterinary Vaccine Distributors List
14.3 Veterinary Vaccine Customers
15 Market Dynamics
15.1 Veterinary Vaccine Market Trends
15.2 Veterinary Vaccine Drivers
15.3 Veterinary Vaccine Market Challenges
15.4 Veterinary Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Veterinary Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Veterinary Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Veterinary Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Veterinary Vaccine Sales (M Doses) by Region (2016-2021)
Table 5. Global Veterinary Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Veterinary Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Veterinary Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Veterinary Vaccine Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Veterinary Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Veterinary Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Veterinary Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Veterinary Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Veterinary Vaccine Sales Share by Company (2016-2021)
Table 14. Global Veterinary Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Veterinary Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Vaccine as of 2020)
Table 17. Global Veterinary Vaccine Average Price (USD/Doses) of Key Company (2016-2021)
Table 18. Manufacturers Veterinary Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Veterinary Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Veterinary Vaccine Sales (M Doses) by Type (2016-2021)
Table 22. Global Veterinary Vaccine Sales Share by Type (2016-2021)
Table 23. Global Veterinary Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Veterinary Vaccine Price (USD/Doses) by Type (2016-2021)
Table 25. Global Veterinary Vaccine Sales Share by Type (2022-2027)
Table 26. Global Veterinary Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Veterinary Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Veterinary Vaccine Price (USD/Doses) by Type (2022-2027)
Table 29. Global Veterinary Vaccine Sales (M Doses) by Application (2016-2021)
Table 30. Global Veterinary Vaccine Sales Share by Application (2016-2021)
Table 31. Global Veterinary Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Veterinary Vaccine Price (USD/Doses) by Application (2016-2021)
Table 33. Global Veterinary Vaccine Sales (M Doses) by Application (2022-2027)
Table 34. Global Veterinary Vaccine Sales Share by Application (2022-2027)
Table 35. Global Veterinary Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Veterinary Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Veterinary Vaccine Price (USD/Doses) by Application (2022-2027)
Table 38. North America Veterinary Vaccine Sales (M Doses) by Company (2016-2021)
Table 39. North America Veterinary Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Veterinary Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Veterinary Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Veterinary Vaccine Sales by Type (2016-2021) & (M Doses)
Table 43. North America Veterinary Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Veterinary Vaccine Sales by Type (2022-2027) & (M Doses)
Table 45. North America Veterinary Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Veterinary Vaccine Sales by Application (2016-2021) & (M Doses)
Table 47. North America Veterinary Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Veterinary Vaccine Sales by Application (2022-2027) & (M Doses)
Table 49. North America Veterinary Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Veterinary Vaccine Sales (M Doses) by Company (2016-2021)
Table 51. Europe Veterinary Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Veterinary Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Veterinary Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Veterinary Vaccine Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Veterinary Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Veterinary Vaccine Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Veterinary Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Veterinary Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Veterinary Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Veterinary Vaccine Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Veterinary Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Veterinary Vaccine Sales (M Doses) by Company (2016-2021)
Table 63. China Veterinary Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Veterinary Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Veterinary Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Veterinary Vaccine Sales by Type (2016-2021) & (M Doses)
Table 67. China Veterinary Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Veterinary Vaccine Sales by Type (2022-2027) & (M Doses)
Table 69. China Veterinary Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Veterinary Vaccine Sales by Application (2016-2021) & (M Doses)
Table 71. China Veterinary Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Veterinary Vaccine Sales by Application (2022-2027) & (M Doses)
Table 73. China Veterinary Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Veterinary Vaccine Sales (M Doses) by Company (2016-2021)
Table 75. Japan Veterinary Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Veterinary Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Veterinary Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Veterinary Vaccine Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Veterinary Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Veterinary Vaccine Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Veterinary Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Veterinary Vaccine Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Veterinary Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Veterinary Vaccine Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Veterinary Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Veterinary Vaccine Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Veterinary Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Veterinary Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Veterinary Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Veterinary Vaccine Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Veterinary Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Veterinary Vaccine Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Veterinary Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Veterinary Vaccine Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Veterinary Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Veterinary Vaccine Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Veterinary Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Veterinary Vaccine Sales (M Doses) by Company (2016-2021)
Table 99. India Veterinary Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Veterinary Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Veterinary Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Veterinary Vaccine Sales by Type (2016-2021) & (M Doses)
Table 103. India Veterinary Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Veterinary Vaccine Sales by Type (2022-2027) & (M Doses)
Table 105. India Veterinary Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Veterinary Vaccine Sales by Application (2016-2021) & (M Doses)
Table 107. India Veterinary Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Veterinary Vaccine Sales by Application (2022-2027) & (M Doses)
Table 109. India Veterinary Vaccine Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 113. Merck Veterinary Vaccine Product
Table 114. Merck Recent Development
Table 115. Zoetis Corporation Information
Table 116. Zoetis Description and Business Overview
Table 117. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 118. Zoetis Veterinary Vaccine Product
Table 119. Zoetis Recent Development
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Veterinary Vaccine Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. Ceva Corporation Information
Table 126. Ceva Description and Business Overview
Table 127. Ceva Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 128. Ceva Veterinary Vaccine Product
Table 129. Ceva Recent Development
Table 130. CAHIC Corporation Information
Table 131. CAHIC Description and Business Overview
Table 132. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 133. CAHIC Veterinary Vaccine Product
Table 134. CAHIC Recent Development
Table 135. HVRI Corporation Information
Table 136. HVRI Description and Business Overview
Table 137. HVRI Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 138. HVRI Veterinary Vaccine Product
Table 139. HVRI Recent Development
Table 140. Ringpu Biology Corporation Information
Table 141. Ringpu Biology Description and Business Overview
Table 142. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 143. Ringpu Biology Veterinary Vaccine Product
Table 144. Ringpu Biology Recent Development
Table 145. Yebio Corporation Information
Table 146. Yebio Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 147. Yebio Description and Business Overview
Table 148. Yebio Veterinary Vaccine Product
Table 149. Yebio Recent Development
Table 150. DHN Corporation Information
Table 151. DHN Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 152. DHN Description and Business Overview
Table 153. DHN Veterinary Vaccine Product
Table 154. DHN Recent Development
Table 155. WINSUN Corporation Information
Table 156. WINSUN Description and Business Overview
Table 157. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 158. WINSUN Veterinary Vaccine Product
Table 159. WINSUN Recent Development
Table 160. Elanco Corporation Information
Table 161. Elanco Description and Business Overview
Table 162. Elanco Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 163. Elanco Veterinary Vaccine Product
Table 164. Elanco Recent Development
Table 165. Virbac Corporation Information
Table 166. Virbac Description and Business Overview
Table 167. Virbac Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 168. Virbac Veterinary Vaccine Product
Table 169. Virbac Recent Development
Table 170. Jinyu Bio-Technology Corporation Information
Table 171. Jinyu Bio-Technology Description and Business Overview
Table 172. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 173. Jinyu Bio-Technology Veterinary Vaccine Product
Table 174. Jinyu Bio-Technology Recent Development
Table 175. ChengDu Tecbond Corporation Information
Table 176. ChengDu Tecbond Description and Business Overview
Table 177. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 178. ChengDu Tecbond Veterinary Vaccine Product
Table 179. ChengDu Tecbond Recent Development
Table 180. CAVAC Corporation Information
Table 181. CAVAC Description and Business Overview
Table 182. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 183. CAVAC Veterinary Vaccine Product
Table 184. CAVAC Recent Development
Table 185. Kyoto Biken Laboratories Corporation Information
Table 186. Kyoto Biken Laboratories Description and Business Overview
Table 187. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 188. Kyoto Biken Laboratories Veterinary Vaccine Product
Table 189. Kyoto Biken Laboratories Recent Development
Table 190. FATRO Corporation Information
Table 191. FATRO Description and Business Overview
Table 192. FATRO Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 193. FATRO Veterinary Vaccine Product
Table 194. FATRO Recent Development
Table 195. Vaksindo Corporation Information
Table 196. Vaksindo Description and Business Overview
Table 197. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 198. Vaksindo Veterinary Vaccine Product
Table 199. Vaksindo Recent Development
Table 200. Bio-Labs Corporation Information
Table 201. Bio-Labs Description and Business Overview
Table 202. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 203. Bio-Labs Veterinary Vaccine Product
Table 204. Bio-Labs Recent Development
Table 205. Avimex Animal Health Corporation Information
Table 206. Avimex Animal Health Description and Business Overview
Table 207. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 208. Avimex Animal Health Veterinary Vaccine Product
Table 209. Avimex Animal Health Recent Development
Table 210. MEVAC Corporation Information
Table 211. MEVAC Description and Business Overview
Table 212. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 213. MEVAC Veterinary Vaccine Product
Table 214. MEVAC Recent Development
Table 215. Biovac Corporation Information
Table 216. Biovac Description and Business Overview
Table 217. Biovac Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 218. Biovac Veterinary Vaccine Product
Table 219. Biovac Recent Development
Table 220. Atafen Corporation Information
Table 221. Atafen Description and Business Overview
Table 222. Atafen Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 223. Atafen Veterinary Vaccine Product
Table 224. Atafen Recent Development
Table 225. Dyntec Corporation Information
Table 226. Dyntec Description and Business Overview
Table 227. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 228. Dyntec Veterinary Vaccine Product
Table 229. Dyntec Recent Development
Table 230. BioTestLab Corporation Information
Table 231. BioTestLab Description and Business Overview
Table 232. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 233. BioTestLab Veterinary Vaccine Product
Table 234. BioTestLab Recent Development
Table 235. RVSRI Corporation Information
Table 236. RVSRI Description and Business Overview
Table 237. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 238. RVSRI Veterinary Vaccine Product
Table 239. RVSRI Recent Development
Table 240. Medion Corporation Information
Table 241. Medion Description and Business Overview
Table 242. Medion Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 243. Medion Veterinary Vaccine Product
Table 244. Medion Recent Development
Table 245. Production Base and Market Concentration Rate of Raw Material
Table 246. Key Suppliers of Raw Materials
Table 247. Veterinary Vaccine Distributors List
Table 248. Veterinary Vaccine Customers List
Table 249. Veterinary Vaccine Market Trends
Table 250. Veterinary Vaccine Market Drivers
Table 251. Veterinary Vaccine Market Challenges
Table 252. Veterinary Vaccine Market Restraints
Table 253. Research Programs/Design for This Report
Table 254. Key Data Information from Secondary Sources
Table 255. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Veterinary Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Livestock Examples
Figure 7. Swine Examples
Figure 8. Chicken Examples
Figure 9. Dog & Cat Examples
Figure 10. Others Examples
Figure 11. Global Veterinary Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Veterinary Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Veterinary Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 14. Global Veterinary Vaccine Price Trends Growth Rate (2016-2027) (USD/Doses)
Figure 15. Global Veterinary Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Veterinary Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Veterinary Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Veterinary Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 19. Europe Veterinary Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Veterinary Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Veterinary Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Veterinary Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Veterinary Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Veterinary Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Veterinary Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Veterinary Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Veterinary Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Veterinary Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Veterinary Vaccine Players Market Share by Revenue in Veterinary Vaccine: 2016 & 2020
Figure 30. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Veterinary Vaccine Revenue Share by Type (2016-2021)
Figure 32. Global Veterinary Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Veterinary Vaccine Revenue Share by Application (2016-2021)
Figure 34. Global Veterinary Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Veterinary Vaccine Sales Market Share by Type in 2020
Figure 36. North America Veterinary Vaccine Sales Market Share by Application in 2020
Figure 37. Europe Veterinary Vaccine Sales Market Share by Type in 2020
Figure 38. Europe Veterinary Vaccine Sales Market Share by Application in 2020
Figure 39. China Veterinary Vaccine Sales Market Share by Type in 2020
Figure 40. China Veterinary Vaccine Sales Market Share by Application in 2020
Figure 41. Japan Veterinary Vaccine Sales Market Share by Type in 2020
Figure 42. Japan Veterinary Vaccine Sales Market Share by Application in 2020
Figure 43. Southeast Asia Veterinary Vaccine Sales Market Share by Type in 2020
Figure 44. Southeast Asia Veterinary Vaccine Sales Market Share by Application in 2020
Figure 45. India Veterinary Vaccine Sales Market Share by Type in 2020
Figure 46. India Veterinary Vaccine Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Veterinary Vaccine
Figure 49. Manufacturing Process Analysis of Veterinary Vaccine
Figure 50. Veterinary Vaccine Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
動物用ワクチンアジュバントのグローバル市場2021 An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vacci…- 動物ワクチン用包装のグローバル市場調査 2019年 The global Veterinary Vaccine Packaging market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Veterinary Vaccine Packaging volume and value at global level, regional level and company level. From a global…
- 動物ワクチン用包装のグローバル市場調査 2019年 The global Veterinary Vaccine Packaging market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Veterinary Vaccine Packaging volume and value at global level, regional level and company level. From a global…
- ニューカッスル病ワクチンのグローバル市場2021 Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens. The classification of New…
- アヒル用ウイルス腸炎ワクチンのグローバル市場調査 2019年 The global Duck Virus Enteritis Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Duck Virus Enteritis Vaccine volume and value at global level, regional level and company level. From a global…